What is the Melanoma Research Institute of Excellence (MRIE)?
In the fight against cancer, the power of research gives promise to the hope for better treatment and cures. Over the course of more than 20 years, the melanoma team at the Sidney Kimmel Cancer Center has established a robust research program unmatched by any other melanoma program in the world. The establishment of the Melanoma Research Institute of Excellence (MRIE) ensures our patients have access to next-generation therapies for notoriously complex cancers.
The Melanoma Research Institute of Excellence at the Sidney Kimmel Cancer Center (SKCC) is a comprehensive program that brings together uveal melanoma and skin melanoma specialties. These programs have a proven track record for pioneering bench-to-bedside innovations, first-in-field therapies, and a breadth of treatment options. Through lab-based, clinical, genetic, and population-based studies, the MRIE is unlocking insights previously unattainable. The goal of the MRIE is simple: better prevention, diagnosis, and treatment strategies for melanoma patients at SKCC and far beyond.
Research is key. Every new discovery brings us closer to new insights, new detection methodologies, and new therapies. It gives us the direction today that will lead to a cure tomorrow.